Related Experiment Video
Updated: Aug 12, 2026

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia
Published on: January 27, 2018
Minimally Invasive Aesthetic Treatments in Men: A Systematic Review and Meta-Analysis
Aina García Dinnbier1, Esmeralda Silva Diaz2, Francisca Ibáñez García3
1Servicio Aragonés de Salud, Huesca, Spain.
Aesthetic treatments like botulinum toxin type A are safe and effective for men, with higher doses improving outcomes. This study analyzed minimally invasive procedures for the male population, finding good response rates and minor side effects.
Area of Science:
- Aesthetic Medicine
- Dermatology
- Plastic Surgery
Background:
- Increasing number of male patients seeking aesthetic treatments.
- Gender-specific factors impact treatment outcomes in men.
- Limited high-quality research on minimally invasive aesthetic procedures for males.
Purpose of the Study:
- Evaluate specificities of aesthetic medicine in male patients.
- Analyze efficacy and safety of treatments for men.
- Identify research gaps in male aesthetic medicine.
Main Methods:
- Systematic review and meta-analysis following PRISMA guidelines.
- Methodological quality assessed using established tools.
- Meta-analysis focused on 5 randomized controlled trials of botulinum toxin type A.
Main Results:
- Included 10 studies with 12,603 male patients.
- Men favored neuromodulators and fillers, often needing higher volumes.
- Botulinum toxin type A showed 85% efficacy for upper facial wrinkles; adverse events were minor (16%).
Conclusions:
- Aesthetic treatments are effective and safe for the male population.
- Higher botulinum toxin A doses enhance outcomes without increased risk.
- Further research is needed to address specific male aesthetic concerns.
More Related Videos
03:47Enhancement of Facial Rejuvenation Through a Combination of 1565 nm Non-Ablative Fractional Laser with 30% Supramolecular Salicylic Acid
Published on: September 27, 2024
03:07Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025